Episode Details
Back to EpisodesExperimental cancer vaccine extending live expectancy
Published 2 months, 3 weeks ago
Description
A deeply compelling innovation has got cancer specialists buzzing. An experimental m-R-N-A cancer vaccine which has allowed people with high-risk melanoma to live longer, cancer-free, according to drug companies Moderna and Merck. Medical Oncologist and Melanoma NZ Spokesperson Gareth Rivalland has been leading this from the New Zealand end joined us to discuss.